Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching - EurekAlert!
Revolutionizing ovarian cancer treatment with adaptive PARP inhibitor therapy
Synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells: implications for novel ... - EurekAlert
